Craig Collard - 10 Sep 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Role
Director
Signature
/s/ Craig Collard
Issuer symbol
OPNT
Transactions as of
10 Sep 2021
Net transactions value
+$174,110
Form type
4
Filing time
13 Sep 2021, 16:08:00 UTC
Previous filing
16 Jun 2021
Next filing
15 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $174,110 +9,577 +239% $18.18 13,577 10 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $18.06 to $18.20. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.